TP53 and colorectal cancer: A key finding was that approximately 15% of small-sized, LGD polyps carried concurrent pathogenic driver mutations in key colorectal cancer signaling pathways, WNT, RTK-RAS, and p53, like those commonly seen in colorectal cancer.